Welcome to our dedicated page for TLAC news (Ticker: TLAC), a resource for investors and traders seeking the latest updates and insights on TLAC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect TLAC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of TLAC's position in the market.
Three Lions Acquisition Corp (Nasdaq: TLACU) priced its initial public offering of 10,000,000 units at $10.00 per unit, for gross proceeds of $100 million. The units are expected to begin trading on the Nasdaq Global Market on September 1, 2026 under the symbol "TLACU".
The company is a special purpose acquisition company aiming for a business combination in the sports, hospitality and leisure, and real estate sectors. Each unit consists of one ordinary share and one-half of one warrant, with each whole warrant exercisable at $11.50 per share. Once separated, shares and warrants are expected to trade under "TLAC" and "TLACW", respectively.
EarlyBirdCapital is sole book-running manager and has a 45-day option to buy up to 1,500,000 additional units at the IPO price to cover over-allotments. The offering is expected to close on or about September 2, 2026, subject to customary conditions.